Peter Altman - 11 May 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
11 May 2022
Transactions value $
$18,586
Form type
4
Filing time
13 May 2022, 18:32:39 UTC
Previous filing
02 May 2022
Next filing
07 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $1.3K +1K +0.3% $1.30 334K 11 May 2022 Direct F1
transaction BCDA Common Stock Purchase $13.6K +11.3K +3.38% $1.20 345K 12 May 2022 Direct F2
transaction BCDA Common Stock Purchase $3.72K +2.7K +0.78% $1.38 348K 13 May 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $1.29 to $1.30 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 This transaction was executed in multiple trades ranging from $1.13 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.